- June 6, 2019
-- Itamar Medical Ltd. a company that develops, manufacturers and markets non-invasive diagnostic devices for sleep apnea with a focus on the cardiology market, and BioTel Heart, a division of BioTelemetry, Inc. the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today announced an expanded collaboration to make Itamar Medical's Total Sleep Solution available to select BioTel Heart cardiology customers in the United States. The companies conducted a successful pilot program with several BioTel Heart customers and are making the service available in additional targeted regions. The collaboration is designed to respond to the growing demand for home sleep apnea testing among cardiologists, who recognize effective sleep apnea management as a critical strategy for improving health in patients with cardiac disease. Itamar Medical's Total Sleep Solution is a comprehensive program that combines products and services, including the company's innovative diagnostic test, the WatchPAT™. It is designed to provide cardiologists who are not board certified in sleep easy access to a comprehensive suite of products and services, including a network of sleep physicians, for quick, cost-effective, diagnosis, treatment and management of patients they suspect suffer from sleep apnea. Products and services in the Total Sleep Solution program include the WatchPAT, CloudPAT™ and SleePATh™ for cloudbased data and information mobilization solutions, and continuous positive airway pressure (CPAP) therapy compliance monitoring and logistical solutions such as WatchPAT Direct™. BioTelemetry is advancing health by providing technology and services that enable healthcare providers to monitor and diagnose patients and clinical research subjects in a more efficient, accurate and cost-effective manner. It is one of the largest and fastest growing connected health companies. BioTel Heart processes over four billion heartbeats per day and monitors over one million patients each year. It is the pioneer in remote patient monitoring, revolutionizing healthcare with its suite of cardiac monitoring devices, including its FDA-cleared ePatch™ and Mobile Cardiac Outpatient Telemetry (MCOT™) monitors. "We are excited to collaborate with BioTel Heart as we seek to leverage the growing opportunities for our WatchPAT technology,"
said Gilad Glick, President and Chief Executive Officer of Itamar Medical. "BioTel Heart has an extensive and trusted network across the cardiology community and a significant footprint in the U.S. Our collaboration provides the framework for cardiologists to prescribe home sleep apnea tests without worrying about pre-authorization and billing. This next step in o "It is estimated that more than half of all patients with cardiovascular disease suffer from sleep apnea, a co-morbidity that has significant health and economic impacts," said Rodney Horton, M.D., F.A.C.C. (Fellow of the American College of Cardiologists)
at Texas Cardiac Arrhythmia. "Diagnosing and managing sleep apnea is an essential component of cardiac care pathways that can improve patient outcomes, but many patients neither have access nor are able to manage the burden of spending a night at a sleep center. Additionally, many cardiology centers do not have the resources or infrastructure to offer home sleep apnea testing directly to their patients. The collaboration between Itamar Medical and BioTel Heart addresses both of these barriers by allowing more cardiology centers to offer home sleep apnea testing to their patients. Cardiologists' ability to integrate Total Sleep Solution into routine care strategies is an excellent option when managing patients with sleep apnea." Dr. Horton is a board-certified cardiac electrophysiologist. He played a pivotal role in developing the WatchPAT HST program and was among the first cardiologists to implement the BioTel Heart solution using WatchPAT for fast and accurate diagnosis of sleep apnea. About BioTelemetry, Inc. and BioTel Heart BioTelemetry, Inc. is the leading remote medical technology company focused on delivery of health information to improve quality of life and reduce cost of care. The company provides remote cardiac monitoring, remote blood glucose monitoring, centralized core lab services for clinical trials and original equipment manufacturing that serves both healthcare and clinical research customers. BioTel Heart is a preeminent provider of remote patient monitoring, processing over four billion heartbeats per day and monitoring over one million patients each year. It is the pioneer in remote patient monitoring, revolutionizing healthcare with its suite of cardiac monitoring devices. More information can be found at www.gobio.com. About Itamar Medical Ltd. Itamar Medical is engaged in research, development, sales and marketing of non-invasive medical devices for the diagnosis of respiratory sleep disorders with a focus on the cardiology market. The Company offers a Total Sleep Solution™ to help physicians provide comprehensive sleep apnea management in a variety of clinical environments to optimize patient care and reduce healthcare costs. Its flagship PAT-based product, the WatchPAT™ device, is a home-use diagnostic device for sleep breathing disorders. It also offers the EndoPAT™ system, an FDA-cleared device to test endothelial dysfunction and to evaluate the risk of heart disease and other cardiovascular diseases. Itamar Medical is a public company traded on the Nasdaq and on the Tel Aviv Stock Exchanges, and is based in Caesarea, Israel with U.S. headquarters based in Atlanta, GA.
Itamar Medical Company Contact Itamar Medical Ltd.